RT Journal Article
SR Electronic
T1 Cisapride: Limited access and alternatives
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 471
OP 472
VO 67
IS 7
A2 Vidt, Donald G.
A1 Richter, Joel E.
YR 2000
UL http://www.ccjm.org/content/67/7/471.abstract
AB The withdrawal of cisapride from the market will present challenges for physicians treating patients with nocturnal heartburn, gastroparesis, and dyspepsia. However, alternatives to the drug exist, and it will continue to be available under a limited-access program for patients for whom other drug treatments fail.